Literature DB >> 9174129

Technical considerations for studying cancer metastasis in vivo.

D R Welch1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9174129     DOI： 10.1023/a:1018477516367

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN： 0262-0898            Impact factor:   5.150


× No keyword cloud information.
  316 in total

1.  Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.

Authors:  B E Miller; F R Miller; G H Heppner
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

2.  The organ distribution of disseminated 51 Cr-labeled tumor cells.

Authors:  B Fisher; E R Fisher
Journal:  Cancer Res       Date:  1967-02       Impact factor: 12.701

3.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

4.  "Seed" to "soil" is a return trip in metastasis.

Authors:  S Togo; H Shimada; T Kubota; A R Moossa; R M Hoffman
Journal:  Anticancer Res       Date:  1995 May-Jun       Impact factor: 2.480

5.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

6.  lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.

Authors:  N Brünner; E W Thompson; M Spang-Thomsen; J Rygaard; K Danø; J A Zwiebel
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 7.  Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis.

Authors:  R S Kerbel; I Cornil; D Theodorescu
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

8.  Effects of shipping on the immune function in mice.

Authors:  M S Landi; J W Kreider; C M Lang; L P Bullock
Journal:  Am J Vet Res       Date:  1982-09       Impact factor: 1.156

Review 9.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

Review 10.  Preclinical models for the evaluation of targeted therapies of metastatic disease.

Authors:  S A Eccles; G Box; W Court; J Sandle; C J Dean
Journal:  Cell Biophys       Date:  1994
View more
  64 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Modeling metastasis biology and therapy in real time in the mouse lung.

Authors:  Arnulfo Mendoza; Sung-Hyeok Hong; Tanasa Osborne; Mohammed A Khan; Kirk Campbell; Joseph Briggs; Ananth Eleswarapu; Lauren Buquo; Ling Ren; Stephen M Hewitt; El Habib Dakir; El-H Dakir; Susan Garfield; Renard Walker; Glenn Merlino; Jeffrey E Green; Kent W Hunter; Lalage M Wakefield; Chand Khanna
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 3.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

4.  Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.

Authors:  Judith M Runnels; Alicia L Carlson; Costas Pitsillides; Brian Thompson; Juwell Wu; Joel A Spencer; John M J Kohler; AbdelKareem Azab; Anne-Sophie Moreau; Scott J Rodig; Andrew L Kung; Kenneth C Anderson; Irene M Ghobrial; Charles P Lin
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

5.  The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis.

Authors:  Cheng-Yu Ko; Lanxiao Wu; Ashwin M Nair; Yi-Ting Tsai; Victor K Lin; Liping Tang
Journal:  Biomaterials       Date:  2011-10-22       Impact factor: 12.479

6.  Nm23-H1: genetic alterations and expression patterns in tumor metastasis.

Authors:  M T Hartsough; P S Steeg
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

7.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

8.  Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.

Authors:  Kedar S Vaidya; Sitaram Harihar; Pushkar A Phadke; Lewis J Stafford; Douglas R Hurst; David G Hicks; Graham Casey; Daryll B DeWald; Danny R Welch
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

9.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

10.  The controversial clinicobiological role of breast cancer stem cells.

Authors:  Claudia Casarsa; Saro Oriana; Danila Coradini
Journal:  J Oncol       Date:  2009-03-19       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.